Skip to main content
Top
Published in: World Journal of Surgery 5/2008

01-05-2008

Pasieka’s Parathyroid Symptoms Scores Correlate with SF-36 Scores in Patients Undergoing Surgery for Primary Hyperparathyroidism

Authors: Radu Mihai, Gregory P. Sadler

Published in: World Journal of Surgery | Issue 5/2008

Login to get access

Abstract

Background

Parathyroidectomy for primary hyperparathyroidism (PHPT) is expected to trigger an improvement in the quality of life. This has been demonstrated previously by using the SF-36 questionnaire, whose interpretation is difficult in routine clinical practice. As an alternative, the 13-item questionnaire developed by Pasieka et al. can be used to assess the severity of symptoms on a visual analogue from which a parathyroid assessment of symptoms score (PAS) can be calculated. The purpose of this study was to correlate results of these two assessment tools.

Methods

Prospective case-series study recruiting consecutive unselected patients who underwent successful parathyroidectomy for PHPT. SF-36(v2) and Pasieka’s questionnaires were collected before parathyroidectomy and at 3, 6, and 12 months postoperatively.

Results

Between November 2005 and December 2006, 101 patients were diagnosed with PHPT (30 men; aged 18–89 years). Preoperative PAS ranged 0–1040 and did not correlate with the severity of hypercalcemia (2.91 ± 0.25; range, 2.56–3.4 mmol/l). Scores from the SF-36 questionnaire were under the 50th percentile for the normal population in three domains (vitality, emotional role, and physical role). Minimally invasive parathyroidectomy was performed in 69 patients and bilateral cervical exploration in 32 patients. All were found to have a single parathyroid adenoma and were normocalcemic at 3–12 months after parathyroidectomy.
At follow-up, there was a significant reduction of PAS from 460 ± 257 preoperatively to 254 ± 234 at 3 months postoperatively (n = 72), to 245 ± 215 at 6 months (n = 50), and 249 ± 212 at 12 months (n = 63) (p < 0.05, Student’s t-test). There was a significant and persistent improvement in five domains of SF-36 questionnaire: bodily pain, general health, vitality, social functioning and mental health. Overall analysis of 244 assessments using both questionnaires demonstrated a negative correlation between increasing PAS and decreasing mental component scores and physical component scores of the SF-36 assessment (r2 = 0.372 and 0.301, respectively).

Conclusions

Pasieka’s parathyroid assessment of symptom scores (PAS) correlate with SF-36 questionnaire scores. Because PAS allows easier and faster analysis, we advocate that Pasieka’s questionnaire should be integrated into the assessment of patients with PHPT as a reliable tool to identify symptomatic changes that correlate with improved quality of life.
Literature
1.
go back to reference Talpos GB, Bone HG 3rd, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128:1013–1020PubMedCrossRef Talpos GB, Bone HG 3rd, Kleerekoper M, Phillips ER, Alam M, Honasoge M, Divine GW, Rao DS (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128:1013–1020PubMedCrossRef
2.
go back to reference Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026PubMedCrossRef Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026PubMedCrossRef
3.
go back to reference Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallie E (2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141:153–159PubMedCrossRef Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallie E (2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141:153–159PubMedCrossRef
4.
go back to reference Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121PubMedCrossRef Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121PubMedCrossRef
5.
go back to reference Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation compared to parathyroidectomy for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687–1692PubMedCrossRef Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation compared to parathyroidectomy for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687–1692PubMedCrossRef
6.
go back to reference Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518PubMedCrossRef Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518PubMedCrossRef
7.
go back to reference Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, Krzywda B (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949PubMedCrossRef Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, Krzywda B (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949PubMedCrossRef
8.
go back to reference Greutelaers B, Kullen K, Kollias J, Bochner M, Roberts A, Wittert G, Pasieka J, Malycha P (2004) Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74:112–115PubMedCrossRef Greutelaers B, Kullen K, Kollias J, Bochner M, Roberts A, Wittert G, Pasieka J, Malycha P (2004) Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74:112–115PubMedCrossRef
9.
go back to reference Mihai R, Sadler G, Wass JAH (2008) Asymptomatic primary hyperparathyroidism – need for multicentre studies. Clinical Endocrinol 68:155–164 Mihai R, Sadler G, Wass JAH (2008) Asymptomatic primary hyperparathyroidism – need for multicentre studies. Clinical Endocrinol 68:155–164
10.
go back to reference Weber T, Keller M, Hense I, Pietsch A, Hinz U, Schilling T, Nawroth P, Klar E, Buchler MW (2007) Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 31:1204–1211CrossRef Weber T, Keller M, Hense I, Pietsch A, Hinz U, Schilling T, Nawroth P, Klar E, Buchler MW (2007) Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 31:1204–1211CrossRef
11.
go back to reference Burney RE, Jones KR, Peterson M, Christy B, Thompson NW (1998) Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 124(6):987–991PubMed Burney RE, Jones KR, Peterson M, Christy B, Thompson NW (1998) Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 124(6):987–991PubMed
12.
go back to reference Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, Tembreull T, Williamson J, Perrier N. (2005) Primary hyperparathyroidism, cognition, health-related quality of life. Ann Surg 242(5):642–650PubMedCrossRef Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, Tembreull T, Williamson J, Perrier N. (2005) Primary hyperparathyroidism, cognition, health-related quality of life. Ann Surg 242(5):642–650PubMedCrossRef
13.
go back to reference Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675–681PubMedCrossRef Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675–681PubMedCrossRef
14.
go back to reference Bilezikian JP, Potts JT Jr, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA Jr (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2–11PubMed Bilezikian JP, Potts JT Jr, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA Jr (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2–11PubMed
15.
go back to reference Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH (2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 239:528–535PubMedCrossRef Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH (2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 239:528–535PubMedCrossRef
16.
go back to reference Kebebew E, Duh QY, Clark OH (2003) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg 138:867–871PubMedCrossRef Kebebew E, Duh QY, Clark OH (2003) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg 138:867–871PubMedCrossRef
17.
go back to reference Egan KR, Adler JT, Olson JE, Chen H (2007) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res 140:194–198PubMedCrossRef Egan KR, Adler JT, Olson JE, Chen H (2007) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res 140:194–198PubMedCrossRef
18.
go back to reference Tang T, Dolan S, Robinson B, Delbridge L (2007) Does the surgical approach affect quality of life outcomes? A comparison of minimally invasive parathyroidectomy with open parathyroidectomy. Int J Surg 5:17–22PubMedCrossRef Tang T, Dolan S, Robinson B, Delbridge L (2007) Does the surgical approach affect quality of life outcomes? A comparison of minimally invasive parathyroidectomy with open parathyroidectomy. Int J Surg 5:17–22PubMedCrossRef
Metadata
Title
Pasieka’s Parathyroid Symptoms Scores Correlate with SF-36 Scores in Patients Undergoing Surgery for Primary Hyperparathyroidism
Authors
Radu Mihai
Gregory P. Sadler
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2008
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9509-9

Other articles of this Issue 5/2008

World Journal of Surgery 5/2008 Go to the issue